PMID: 8614066May 1, 1996Paper

Inhibition of the biologic activity of tumor necrosis factor maintains vascular endothelial cell function during hyperdynamic sepsis

The Journal of Trauma
P WangI H Chaudry

Abstract

Although vascular endothelial cell function (i.e., the release of endothelium-derived nitric oxide) decreases and plasma tumor necrosis factor (TNF) increases during sepsis, it is not known whether the elevated TNF is responsible for the depression of endothelial cell function under such conditions. The aim of this study, therefore, was to determine if inhibition of TNF biologic activity by polyethylene glycol dimerized conjugate of the recombinant human form of the p55 soluble TNF receptor (PEG-(rsTNF-R1)2) maintains endothelial function during sepsis. Rats were subjected to sepsis by cecal ligation and puncture (CLP). Immediately before the onset of sepsis, 600 microgram/rat PEG-(rsTNF-R1)2 or an equal volume of saline was infused intravenously. At 10 hours after CLP (i.e., hyperdynamic sepsis), the thoracic aorta was isolated, cut into rings, and placed in organ chambers. Dose responses for an endothelium-dependent vasodilator, acetylcholine (ACh), and an endothelium-independent vasodilator, nitroglycerine (NTG), were determined. Endothelial cell structure was examined by transmission electron microscopy. Endothelium-dependent vascular relaxation was depressed at 10 hours after the onset of sepsis. Administration of PEG-(rsT...Continue Reading

References

May 29, 1992·Biochemical and Biophysical Research Communications·R A Pittner, J A Spitzer
Dec 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·A AshkenaziD H Smith
Nov 1, 1991·Hypertension·J T Shepherd, Z S Katusić
Oct 1, 1989·Critical Care Medicine·P DamasP Franchimont
Apr 1, 1995·Annals of Surgery·T R Billiar
Nov 1, 1994·Archives of Surgery·P WangI H Chaudry
Apr 1, 1994·The American Journal of Physiology·Y P Wang, F Fuchs
Nov 1, 1993·The American Journal of Physiology·Z WangL J Mordan
Jul 1, 1993·Annals of Surgery·A C DrostB A Pruitt
Oct 1, 1993·Critical Care Medicine·R M StrieterR C Bone

❮ Previous
Next ❯

Citations

Jul 11, 2001·Critical Care Medicine·B Vallet, E Wiel
Jun 9, 2005·Critical Care Medicine·Stéphanie RignaultFrançois Feihl
May 4, 2004·British Journal of Anaesthesia·H F Galley, N R Webster

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.